Deerfield-based Baxter International announced Monday that its CEO and board Chair José Almeida is retiring, effective ...

Vantive builds on a 70-year legacy of kidney care leadership and innovation, with a singular focus on empowering patients and ...

Baxter Chair, President and CEO Joe Almeida [Photo courtesy of Baxter] Baxter (NYSE: BAX) + announced today that José (Joe) E ...

Baxter President and CEO José Almeida has announced his retirement, effective immediately, after nearly a decade of leading ...

Vantive, formerly the Baxter Kidney Care segment, launched as a new standalone vital organ therapy company following the completion of its ...

Baxter International, Inc. BAX recently announced that it has entered into a definitive agreement to divest its Vantive ...

Concluding a two-year journey, Baxter International Inc.’s kidney care unit finally separated from the company and started a new life as Vantive, following the closing on Jan. 31 of its $3.8 billion ...

The kidney care business – spanning dialysis machines and related supplies and services – will be renamed Vantive once the sale is concluded, said Baxter in a statement. Carlyle is buying the ...

Baxter (BAX) announced that Jose Almeida, chair, president and CEO, will retire from his executive roles with the company, effective ...

Baxter stock tumbled Tuesday, undercutting its 50-day line, after the medtech company agreed to sell its kidney segment to Carlyle for $3.8 billion. Please watch the video at Investors.com - How ...

Baxter International Inc. (NYSE:BAX), a global medtech leader, announced today the mission and logo for its proposed kidney care and acute therapies company, to be named Vantive. This press ...